Trials / Unknown
UnknownNCT01301690
Development of a Novel Methodology Using BMVC Staining as an Assistance to Cancer Cytological Diagnosis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Far Eastern Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
3,6-bis(1-methyl-4-vinylpyridinium) carbazole diiodide (BMVC) is an inorganic chemical compound (Figure1). The uptake of BMVC in cancer cells and normal cells are different. Recently, a simple handheld device (Figure1) based on the fluorescence analysis of stained cells was established to instantly differentiate cancer cells from normal cells. The investigators want to quantitatively measure the fluorescence expression of BMVC in normal and cancer cells and explore the usefulness of this staining in head and neck lumps.
Conditions
Timeline
- Start date
- 2010-01-01
- First posted
- 2011-02-23
- Last updated
- 2011-09-19
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01301690. Inclusion in this directory is not an endorsement.